ACADIA Pharmaceuticals Inc (ACAD)
17.24
+0.24
(+1.41%)
USD |
NASDAQ |
Apr 23, 09:53
ACADIA Pharmaceuticals Market Cap: 2.841B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 2.801B |
| April 19, 2024 | 2.771B |
| April 18, 2024 | 2.813B |
| April 17, 2024 | 2.832B |
| April 16, 2024 | 2.814B |
| April 15, 2024 | 2.783B |
| April 12, 2024 | 2.824B |
| April 11, 2024 | 2.869B |
| April 10, 2024 | 2.921B |
| April 09, 2024 | 2.991B |
| April 08, 2024 | 2.933B |
| April 05, 2024 | 2.968B |
| April 04, 2024 | 2.974B |
| April 03, 2024 | 3.035B |
| April 02, 2024 | 2.984B |
| April 01, 2024 | 3.009B |
| March 28, 2024 | 3.047B |
| March 27, 2024 | 2.999B |
| March 26, 2024 | 2.931B |
| March 25, 2024 | 2.940B |
| March 22, 2024 | 2.958B |
| March 21, 2024 | 3.033B |
| March 20, 2024 | 3.075B |
| March 19, 2024 | 3.081B |
| March 18, 2024 | 3.085B |
| Date | Value |
|---|---|
| March 15, 2024 | 3.045B |
| March 14, 2024 | 3.086B |
| March 13, 2024 | 3.223B |
| March 12, 2024 | 3.292B |
| March 11, 2024 | 3.976B |
| March 08, 2024 | 3.862B |
| March 07, 2024 | 3.875B |
| March 06, 2024 | 3.823B |
| March 05, 2024 | 3.923B |
| March 04, 2024 | 3.913B |
| March 01, 2024 | 3.956B |
| February 29, 2024 | 3.829B |
| February 28, 2024 | 3.912B |
| February 27, 2024 | 4.343B |
| February 26, 2024 | 4.268B |
| February 23, 2024 | 4.083B |
| February 22, 2024 | 4.095B |
| February 21, 2024 | 4.098B |
| February 20, 2024 | 4.092B |
| February 16, 2024 | 4.134B |
| February 15, 2024 | 4.146B |
| February 14, 2024 | 4.208B |
| February 13, 2024 | 4.208B |
| February 12, 2024 | 4.406B |
| February 09, 2024 | 4.340B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.100B
Minimum
Jun 21 2022
9.028B
Maximum
Dec 01 2020
4.567B
Average
3.888B
Median
Market Cap Benchmarks
| Tonix Pharmaceuticals Holding Corp | 15.27M |
| Amylyx Pharmaceuticals Inc | 134.55M |
| Regulus Therapeutics Inc | 143.37M |
| Minerva Neurosciences Inc | 17.83M |
| Viking Therapeutics Inc | 6.502B |
Market Cap Related Metrics
| PS Ratio | 3.894 |
| Price to Book Value | 6.579 |
| Price | 17.24 |
| Earnings Yield | -2.20% |